South Korea - Healthcare, Regulatory and Reimbursement Landscape

1.1 List of Figures
1.2 List of Tables

2.1 Executive Summary
2.2 Key Highlights - Facts about the South Korea Healthcare Market
2.3 Key Highlights: Healthcare Startups in South Korea
2.4 Key Events: South Korea Pharmaceutical News, 2015 - 2021
2.5 Key Events: South Korea Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020 - 2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, South Korea, 2021

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, South Korea
3.5 Pharmaceutical Market - Market Segments
3.6 COVID-19 Epidemiology, South Korea
3.7 COVID-19 Impact and Developments in the Healthcare Market, South Korea
3.9 Pharmaceutical Market - Major Players

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5.1 Drivers
5.2 Barriers

6.1 Deal Analysis: Pharmaceutical Market, South Korea, 2019 - 2021
6.2 Deal Analysis: Medical Device Market, South Korea, 2019 - 2021

7.1 HealthTech Landscape, South Korea
7.2 HealthTech Deals Landscape, South Korea
7.3 Adoption of Technology in Healthcare, South Korea
7.4 Key HealthTech Deals, South Korea
7.5 Digital Statistics, South Korea
7.6 HealthTech Landscape, South Korea
7.7 Digital Regulations, South Korea
7.8 COVID-19 Impact on Digital Health, South Korea
7.9 HealthTech Landscape: Benefits and Risks, South Korea

8.1 Overview of Healthcare System, South Korea
8.2 Reimbursement Process, South Korea
8.3 Overview of Insurance Providers, Public Insurance, South Korea
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, South Korea
8.5 Pricing Policies, South Korea
8.6 Regulatory Landscape, South Korea
8.6.1 Marketing Authorization for Pharmaceutical Products, South Korea
8.6.2 Marketing Authorization for Generic Medicines, South Korea
8.6.3 Marketing Authorization for OTC, South Korea
8.6.4 Marketing Authorization for Biologics and Biosimilars, South Korea
8.6.5 Pharmaceutical Market - Drug Approvals
8.6.6 Marketing Authorization for Medical Devices, South Korea
8.6.7 Pharmaceutical Export and Import, South Korea
8.6.8 Intellectual Property Rights, South Korea
8.6.9 Intellectual Property Rights, Patent, South Korea
8.6.10 Intellectual Property Rights, Trademark, South Korea
8.6.11 Clinical Trial Regulation Process, South Korea
8.6.12 Pharmaceutical Clinical Trials Landscape, South Korea
8.6.13 Medical Device Clinical Trials Landscape, South Korea
8.6.14 Pharmaceutical Advertising Regulations, South Korea
8.6.15 Pharmacy Regulations, South Korea
8.6.16 Labeling and Packaging Regulations, South Korea

9.1 South Korean Healthcare Policy Highlights
9.2 Healthcare Facilities, South Korea
9.3 Life Expectancy and Immunization Rate, South Korea
9.4 Environmental Health, South Korea
9.5 Healthcare Personnel, South Korea
9.6 Disease Burden, South Korea
9.7 Healthcare Expenditure, South Korea

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About The Publisher
13.4 Contact The Publisher
13.5 Disclaimer

Table 1: Approved Biosimilars, South Korea, 2020
Table 2: Key Approved Biologics, South Korea, 2020 - 2021
Table 3: Top 5 Imported Products, OTC Market ($M), South Korea, 2020
Table 4: COVID-19 Indicators, Global and South Korea, 2020 - 2021
Table 5: COVID-19-Related Travel Restrictions, South Korea, 2020 - 2021
Table 6: Authorized COVID-19 Vaccines, South Korea, 2020 - 2021
Table 7: Available COVID-19 IVD Products, South Korea, 2020 - 2021
Table 8: Pipeline COVID-19 IVD Products, South Korea, 2020 - 2021
Table 9: Medical Devices Market, South Korea, Major Segments ($M), 2020
Table 10: Hospital Supplies Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: General Surgery Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Dental Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 13: Cardiovascular Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 14: Orthopedic Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 15: Insurance Contribution Rates, South Korea, 2021
Table 16: Co-payment Ceiling System, South Korea, 2021
Table 17: National Long-Term Care Insurance System vs. Previous Elderly Benefit Service System, South Korea, 2021
Table 18: Pricing by Drug Type, South Korea, 2018
Table 19: OTC Monograph Therapeutic Categories, South Korea, 2021
Table 20: MFDA Gap Analysis of Biosimilar Guidelines for the Extrapolation of Indications, South Korea, 2021
Table 21: Medical Devices Classification, South Korea, 2021
Table 22: Patent Fees, South Korea, 2021
Table 23: Trademark Application Fee, South Korea, 2021
Table 24: Drug Container and Package Information, South Korea, 2021
Table 25: Package Insert Information, South Korea, 2021
Table 26: Conferences and Trade Fairs, South Korea

Figure 1: Pharmaceutical Market, South Korea, Revenue ($B and KRWM), 2013 - 2020
Figure 2: Medical Devices Market, South Korea, Revenue ($M), 2016 - 2021
Figure 3: Healthcare Start-Ups in South Korea, 2021
Figure 4: Country Profile, South Korea, 2021
Figure 5: Pharmaceutical Market, South Korea, Revenue ($B), 2013 - 2020
Figure 6: Pharmaceutical Market, South Korea, Revenue Forecast ($B), 2021 - 2026
Figure 7: Pharmaceutical Exports ($B), South Korea, 2011 - 2020
Figure 8: Top Export Partners, South Korea, 2020
Figure 9: Pharmaceutical Imports ($B), South Korea, 2011 - 2020
Figure 10: Top Import Partners, South Korea, 2020
Figure 11: Process of Assigning the Korea Drug Code, South Korea, 2021
Figure 12: Drug Supply and Reporting Process of Drug Transaction Records, South Korea, 2021
Figure 13: Major Bio-health Clusters, South Korea, 2021
Figure 14: Number of Biosimilar and Biologics Drug Approvals, South Korea, 2016 - 2020
Figure 15: Top Biopharma Companies (by Sales, $M), South Korea, Jan 2021-Jun 2021
Figure 16: Patent Expirations of Major Biologics, South Korea, 2021
Figure 17: OTC Medicines Market, (per Capita Expenditure [$B]), South Korea, 2010 - 2020
Figure 18: OTC Medicines Market, Market Value ($M), South Korea, 2012 - 2020
Figure 19: OTC Medicines Market, Major Market Value Segmentation (%), South Korea, 2019
Figure 20: Therapeutic Area by Sales per Capita ($/person), South Korea, 2019
Figure 21: Therapeutic Area by Pharmaceutical Consumption (DDD/1, 000 person/day), South Korea, 2018
Figure 22: COVID-19 (Number of Deaths), South Korea, 2020 - 2021
Figure 23: COVID-19 (Number of Cases), South Korea, 2020 - 2021
Figure 24: COVID-19 Fiscal Stimulus Timeline, South Korea, 2020 - 2021
Figure 25: COVID-19 Vaccine Dose Administration, Number of Vaccine Doses Administered, South Korea, 2021
Figure 26: COVID-19 Clinical Trials Sponsors by Count, South Korea, 2020 - 2021
Figure 27: COVID-19 Clinical Trials Count by Phase, South Korea, 2020 - 2021
Figure 28: COVID-19 Clinical Trials Count by Trial Status, South Korea, 2020 - 2021
Figure 29: Medical Devices Market, South Korea, Revenue ($B), 2016 - 2020
Figure 30: Medical Devices Market, South Korea, Revenue Forecast ($B), 2021 - 2026
Figure 31: Medical Devices Market, South Korea, Major Segments (%), 2020
Figure 32: Hospital Supplies Market, South Korea, Revenue ($M), 2016 - 2024
Figure 33: Hospital Supplies Market, South Korea, Market Share of Major Players (%), 2020
Figure 34: General Surgery Market, South Korea, Revenue ($M), 2016 - 2023
Figure 35: General Surgery Market, South Korea, Market Share of Major Players (%), 2020
Figure 36: Dental Devices, South Korea, Revenue ($M), 2016 - 2023
Figure 37: Dental Devices, South Korea, Market Share of Major Players (%), 2020
Figure 38: Cardiovascular Devices, South Korea, Revenue ($M), 2016 - 2023
Figure 39: Cardiovascular Devices, South Korea, Market Share of Major Players (%), 2020
Figure 40: Orthopedic Devices, South Korea, Revenue ($M), 2016 - 2023
Figure 41: Orthopedic Devices, South Korea, Market Share of Major Players (%), 2020
Figure 42: Diagnostic Market, South Korea, Revenue ($M), 2016 - 2021
Figure 43: Diagnostic Market, South Korea, Revenue ($M), 2022 - 2027
Figure 44: Deals Value and Deal Count, Pharmaceutical Market, South Korea, 2019 - 2021
Figure 45: Deals Value and Deal Count Subtypes, Pharmaceutical Market, South Korea, 2019 - 2021
Figure 46: Deals Value and Deal Count, Quarterly, Pharmaceutical Market, South Korea, 2019 - 2021
Figure 47: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, South Korea, 2019 - 2021
Figure 48: M&A Deals by Quarter, Pharmaceutical Market, South Korea, 2019 - 2021 (by Value and by Number)
Figure 49: Top Therapy Areas by Deal Count, Pharmaceutical Market, South Korea, 2019 - 2021
Figure 50: Private Equity Deals by Quarter, Pharmaceutical Market, South Korea, 2019 - 2021 (by Value and by Number)
Figure 51: Deals Value and Deal Count, Medical Devices Market, South Korea, 2019 - 2021
Figure 52: Deals Value and Deal Count Subtypes, Medical Devices Market, South Korea, 2019 - 2021
Figure 53: Deals Value and Deal Count, Quarterly, Medical Devices Market, South Korea, 2019 - 2021
Figure 54: Top Equipment Sectors by Deal Value ($M), Medical Devices Market, South Korea, 2019 - 2021
Figure 55: M&A Deals by Quarter, Medical Devices Market, South Korea, 2019 - 2021 (by Value and by Number)
Figure 56: Top Equipment Sectors by Deal Count, Medical Devices Market, South Korea, 2019 - 2021
Figure 57: VF Deals by Quarter, Medical Devices Market, South Korea, 2019 - 2021 (by Value and by Number)
Figure 58: Deals Value ($M), HealthTech, South Korea, 2019 - 2021
Figure 59: Deal Count (Number of Deals), HealthTech, South Korea, 2019 - 2021
Figure 60: Digital Statistics, South Korea
Figure 61: Key Goals: Digital New Deal, South Korea, 2021
Figure 62: Key Policy Highlights: Digital New Deal, South Korea, 2021